BACK

 

Research

 

 

The department of Bio-organic Chemistry was established only recently; in November 2007. Before that time the group was embedded in the department of Synthetic Organic Chemistry.

In the field of asymmetric synthesis and catalysis, within the group of Prof. Feringa and in collaboration with Prof. de Vries (DSM), we have contributed significantly over the last number of years to the development and application of catalytic asymmetric hydrogenation, catalytic asymmetric conjugate addition and catalytic asymmetric allylic substitution reactions. In the area of asymmetric hydrogenation, novel catalysts have been developed and new substrate classes have been introduced that upon hydrogenation afforded useful building blocks in excellent yield and enantioselectivity.

The isomerisation-free reduction of carbon-carbon double bonds using a Vitamine B2 inspired catalyst (Smit, Fraaije, and Minnaard, J. Org. Chem. 2008)

In the field of copper-catalyzed asymmetric conjugate addition and allylic substitution, considerable progress including several breakthroughs has been made over the past years. The asymmetric conjugate addition of dialkylzincs has been, together with several other groups around the world, brought further to perfection in terms of yield and enantioselectivity. Also the substrate scope was considerably expanded, including several nitrogen containing building blocks that were before only available via long synthetic routes with chiral auxiliaries. In this period also the long sought for catalytic asymmetric conjugate addition of Grignard reagents has been developed. This approach is more practical, though less functional group tolerant, than the dialkylzinc addition. The conjugate addition of Grignard reagents has been applied in both cyclic and linear substrates, expanded to double unsaturated compounds and for various Michael acceptors. Also a thorough mechanistic study on the reaction was carried out. In the closely related, but considerably less developed, catalytic asymmetric allylic substitution reaction considerable progress has been obtained as well, making this reaction now suitable for synthesis.

A recent example from our research in asymmetric hydrogenation is the synthesis of Fosmidomycin analogues, which are mimics of 1-deoxy-D-xylulose 5 phosphate. The latter compound is an intermediate in terpene biosynthesis and the corresponding enzyme is an important target in anti-malaria research.

The synthesis of enantiopure compounds that are chiral on phosphorus is a challenge already for decades. These compounds are obviously very important as ligands for homogeneous catalysis. Together with collaborators we reported recently on a convenient preparative method for the synthesis of enantiopure t-butylphenylphosphine oxide based on the resolution via diastereomeric complex formation.

On the use of enzymes in organic synthesis we focused successfully on the preparation of enantiopure building blocks.

In our natural product synthesis work, next to two alkaloids several complex mycobacterial glycolipids and polyketides have been prepared, all of them for the first time. This has allowed a collaboration with the group of Prof. M.B. Moody (Harvard Medical School) on the immunology and chemical biology of Mycobacterium tuberculosis. In these syntheses, and in the synthesis of various feromones and alkaloids, the asymmetric conjugate addition of dialkylzincs and Grignard reagents has been applied very successfully.

The asymmetric conjugate addition and direct addition of arylboronic acids and arylsiloxanes has been studied both with rhodium and palladium catalysts. We were the first to report the Pd-catalyzed asymmetric conjugate addition of arylboronic acids and aryl siloxanes.

This Web Page Created with PageBreeze Free HTML Editor